TABLE 1

Quantitative evaluation of drug-drug interactions with MTX using human kidney slices

Human kidney slices were incubated with buffer containing [3H]MTX in the presence or absence of inhibitors, and Ki values were determined by nonlinear regression analysis (Fig. 3). Plasma unbound concentrations of the inhibitors (Iu) were calculated from the total plasma concentrations and unbound fractions.

Inhibitors Clinical Concentration KiR Value
Total Iu
μM
Salicylate 1100-2200a 55-440 18.4 ± 8.6 0.040-0.25
Diclofenac 3.6b <0.018 26.6 ± 5.2 1.0
Indomethacin 0.84-84a 0.084-8.4 3.11 ± 1.58 0.27-0.97
Ketoprofen 12a 0.0096 1.85 ± 0.96 1.0
Naproxen >217a 0.651 14.3 ± 5.3 0.96
Phenylbutazone 162-786a 6.3-19.0 4.87 ± 1.4 0.20-0.44
Probenecid 170a 18.7 0.171 ± 0.8 0.009
Ciprofloxacin 7.6c 4.5 >1000 1.0
  • a Takeda et al. (2002).

  • b Riess et al. (1978).

  • c Brunton et al. (2006).